Riskpilot← Back to searchSign inGet full accessA-PHARMA ApS
APSDissolvedCVR 27206115Hovedgaden 55B, 2.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2003— employees
Revenue 2024
DKK 0
EBITDA margin
—
-47% vs 2023
Equity ratio
-401675.0%
Financial strength
Net profit 2024
DKK -96K
-6% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK -15K | -47% |
| Net profit | DKK -96K | -6% |
| Total assets | DKK 553 | +0% |
| Equity | DKK -2,2M | -5% |
| Employees | — | — |
Legal name
A-PHARMA ApS
CVR number
27206115
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
18. juni 2003
Share capital
DKK 200.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening eller af Hans Henrik Raith alene
Address
Hovedgaden 55B, 2.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.818 | -1.188 | 4.087 | 21 | — | -26 | -31 | -12 | -9 | 0 | -7 | 0 | 0 |
| Staff expenses | -1.756 | -959 | -2 | -0 | -0 | -0 | -0 | -2 | -2 | -0 | -0 | -0 | -0 |
| EBITDA | -2.352 | -2.147 | 3.977 | -560 | 0 | -26 | -31 | -14 | -11 | 0 | -7 | -10 | -15 |
| Depreciation & amort. | 72 | -38 | -0 | -1.121 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -2.424 | -2.185 | 3.977 | -1.681 | 0 | -26 | -31 | -14 | -11 | 0 | -7 | -10 | -15 |
| Net financials | -331 | -493 | -255 | -87 | 0 | -1 | -38 | -1 | -78 | -0 | -2 | -81 | -81 |
| Profit before tax | -2.755 | -2.679 | 3.722 | -1.768 | 0 | -27 | -68 | -15 | -89 | -0 | -9 | -91 | -96 |
| Tax | 576 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -3.331 | -2.679 | 3.722 | -1.768 | 0 | -27 | -68 | -15 | -89 | -0 | -9 | -91 | -96 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 9.234 | 5.118 | 3.287 | 584 | 0 | 625 | 12 | 0 | 0 | 0 | 1 | 1 | 1 |
| Equity | -1.639 | -4.317 | 200 | -2.363 | 0 | -1.853 | -1.921 | -1.937 | -2.026 | -2.026 | -2.035 | -2.125 | -2.221 |
| Long-term debt | 2.265 | 2.278 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8.608 | 7.158 | 2.124 | 2.947 | 0 | 2.478 | 1.934 | 1.937 | 2.026 | 2.026 | 2.035 | 2.126 | 2.222 |
| Total debt | 10.873 | 9.436 | 2.124 | 2.947 | 0 | 2.478 | 1.934 | 1.937 | 2.026 | 2.026 | 2.035 | 2.126 | 2.222 |
EBITDA margin
-1471500.0%
This company
15.8%
Market median
-9313391% vs market
20122024
Equity ratio
-401675.0%
This company
38.2%
Market median
-1051605% vs market
20122024
Return on equity
-9593100.0%
This company
18.4%
Market median
-52136513% vs market
20122024
Net profit margin
-9593100.0%
This company
8.1%
Market median
-118433433% vs market
20122024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JG Management | Management | 2008 | — | — |
AS Management | Management | 2003 | — | — |
JT Unofficial title | Unofficial title | 2009 | — | — |
HH Management | Management | 2012 | — | — |
EB Management | Management | 2009 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
HHR HOLDING A/S | Company | 100.0% | 100.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of A-PHARMA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jacob Gade | Management | 0 companies |
| Anni Søgaard | Management | 0 companies |
| Jesper Trommer Volf | Unofficial title | 0 companies |
| Hans Henrik Raith | Management | 0 companies |
| Erik Bjørn Fürsterling | Management | 0 companies |